ICMR-National Institute of Cholera and Enteric Diseases
आई
सी एम आर - राष्ट्रीय कॉलरा और आंत्र रोग संस्थान
Department of Health Research, Ministry of Health and Family Welfare, Government of India
स्वास्थ्य अनुसंधान विभाग, स्वास्थ्य और परिवार कल्याण मंत्रालय, भारत सरकार
WHO Collaborating Centre For Research and Training On Diarrhoeal Diseases
Publications
Patel K, Nayak B, Rana S, Krishnan P,
Tandale BV, Basak S, Sinha A, Kumar MS, Borah P,
Singh H, Gupta N, Dutta S, Mohan A, Das MK,
Landge Y, Ganguly B, Devi U, Pati S, Palo SK.
Enablers and barriers towards ensuring routine
immunization services during the COVID-19
pandemic: findings from a qualitative study
across five different states in India. Trans R
Soc Trop Med Hyg. 2022 Mar 2:trac011. doi:
10.1093/trstmh/trac011. Epub ahead of print.
Sarkar R, Saha R, Mallick P, Sharma R, Kaur
A, Dutta S, et al. Emergence of a novel
SARS-CoV-2 Pango lineage B.1.1.526 in West
Bengal, India. J Infect Public Health. 2022 Jan
1;15(1):42-50.
Ghosh M, Basak S, Dutta S. Underlying
selection for the diversity of spike protein
sequences of SARS-CoV-2. IUBMB Life.
2022;74(3):213-20.
Sarkar MA, Ozair A, Singh KK, Subash NR,
Bardhan M, Khulbe Y. SARS-CoV-2 Vaccination in
India: Considerations of Hesitancy and Bioethics
in Global Health. Ann Glob Health. 2021 Dec
10;87(1):124.
Ella R, Reddy S, Blackwelder W, Potdar V,
Yadav P, Sarangi V, et al. Efficacy, safety, and
lot-to-lot immunogenicity of an inactivated
SARS-CoV-2 vaccine (BBV152): interim results of
a randomised, double-blind, controlled, phase 3
trial. Lancet. 2021 Nov 11;398(10317):2173-84.
Gupta N, Kaur H, Yadav PD, Mukhopadhyay L,
Sahay RR, Kumar A, et al. Clinical
characterization and genomic analysis of samples
from covid-19 breakthrough infections during the
second wave among the various states of india.
Viruses. 2021;13(9).
Murhekar MV, Bhatnagar T, Thangaraj JWV,
Saravanakumar V, Santhosh Kumar M, et al. (2021)
Seroprevalence of IgG antibodies against
SARS-CoV-2 among the general population and
healthcare workers in India, June-July 2021: A
population-based cross-sectional study. PLOS
Medicine 18(12): e1003877.
Tewari DN, Chakrabarti AK, Dutta S. Prospect
of Ion Channel Inhibitors and Cholesterol
Lowering Drugs to Combat COVID-19. J Emerg Dis
Virol. 2021;6(2):1-3.
Yadav PD, Nyayanit DA, Majumdar T, Patil S,
Kaur H, Gupta N, et al. An Epidemiological
Analysis of SARS-CoV-2 Genomic Sequences from
Different Regions of India. Viruses.
2021;13(5):925.
Sarkar A, Chakrabarti AK, Dutta S. Covid-19
infection in India: A comparative analysis of
the second wave with the first wave. Pathogens.
2021 Sep 21;10(9):1222.
Bhatta M, Nandi S, Dutta S, Saha MK.
Coronavirus (SARS-CoV-2): a systematic review
for potential vaccines. Hum Vaccin Immunother.
2021 Feb 5:1-18.
Sarkar R, Mitra S, Chandra P, Saha P,
Banerjee A, Dutta S, et al. Comprehensive
analysis of genomic diversity of SARS-CoV-2 in
different geographic regions of India: an
endeavour to classify Indian SARS-CoV-2 strains
on the basis of co-existing mutations. Arch Virol. 2021 Jan 19;166(3):801-12.
Biswas S, Ghosh P, Chakraborty D, Chatterjee
A, Dutta S, Saha MK. COVID-19 Infection: Data
Gaps for Diagnostic Laboratory Preparedness and
Tasks on Hand. Viral Immunol. 2021;34(3):158-64.
Murhekar M V., Bhatnagar T, Selvaraju S,
Saravanakumar V, Thangaraj JWV, Shah N, et al.
SARS-CoV-2 antibody seroprevalence in India,
August-September, 2020: findings from the second
nationwide household serosurvey. Lancet Glob
Heal. 2021 Mar 1;9(3):e257-66.
Murhekar M V., Bhatnagar T, Thangaraj JWV,
Saravanakumar V, Kumar MS, Selvaraju S, et al.
SARS-CoV-2 sero-prevalence among general
population and healthcare workers in India,
December 2020 - January 2021. Int J Infect Dis.
2021;108:145-55.
Maitra A, Sarkar MC, Raheja H, Biswas NK,
Chakraborti S, Singh AK, et al. Mutations in
SARS-CoV-2 viral RNA identified in Eastern
India: Possible implications for the ongoing
outbreak in India and impact on viral structure
and host susceptibility. J Biosci.
2020;45(1):1-18.
Gupta N, Potdar V, Praharaj I, Giri S, Sapkal
G, Yadav P, et al. Laboratory preparedness for
SARS-CoV-2 testing in India: Harnessing a
network of Virus Research & Diagnostic
Laboratories. Indian J Med Res.
2020;151(2):216-25.
Biswas A, Bhattacharjee U, Chakrabarti AK,
Tewari DN, Banu H, Dutta S. Emergence of Novel
Coronavirus and COVID-19: whether to stay or die
out? Crit Rev Microbiol. 2020;46(2):182-93.
Banerjee A, Sarkar R, Mitra S, Lo M, Dutta S,
Chawla-Sarkar M. The Novel Coronavirus Enigma:
Phylogeny and Analyses of Coevolving Mutations
Among the SARS-CoV-2 Viruses Circulating in
India. JMIR Bioinforma Biotechnol.
2020;1(1):e20735.
Chatterjee P, Anand T, Singh KJ, Rasaily R,
Singh R, Das S, Singh H, Praharaj I,
Gangakhedkar RR, Bhargava B, Panda S. Healthcare
workers & SARS-CoV-2 infection in India: A
case-control investigation in the time of
COVID-19. Indian J Med Res. 2020
May;151(5):459-467.
Kumar M, Bhatnagar T, Manickam P, Kumar V,
Rade K, Shah N, et al. National sero-surveillance
to monitor the trend of SARS-CoV-2 infection
transmission in India: Protocol for
community-based surveillance. Indian J Med Res.
2020 May 1;151(5):419-23.
Chakraborty D, Debnath F, Biswas S, Bhatta M,
Ganguly S, Deb AK, et al. Exploring Repurposing
Potential of Existing Drugs in the Management of
COVID-19 Epidemic: A Critical Review. J Clin Med
Res. 2020;12(8):463-71.
Murhekar M V., Bhatnagar T, Selvaraju S, Rade
K, Saravanakumar V, Thangaraj JWV, et al.
Prevalence of SARS-CoV-2 infection in India:
Findings from the national serosurvey, May-June
2020. Indian J Med Res. 2020;152(1):48-60.
